Patrick says people with a small amount to lose could try fasting first. The piece cites reviews finding results similar to calorie cutting, while noting GLP-1s suit obesity.
Recap by typeshit. Full story at AOL.com.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
On the Great Company podcast, Osbourne warns any medicine can be misused and links his view of Ozempic to his own struggles with body image as a kid.
Loading…